000			02011 a2200577 4500
005			20250513104847.0
264		0	_c19970107
008			199701s 0 0 eng d
022			_a0950-9232
040			_aNLM _beng _cNLM
100	1		_aVogt, A
245	0	0	_aProtein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. _h[electronic resource]
260			_bOncogene _cNov 1996
300			_a1991-9 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aActins _xdrug effects
650	0	4	_aAlkyl and Aryl Transferases
650	0	4	_aAnimals
650	0	4	_aBenzamides _xpharmacology
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCell Transformation, Neoplastic _xgenetics
650	0	4	_aCells, Cultured
650	0	4	_aCytoskeleton _xdrug effects
650	0	4	_aDNA _xbiosynthesis
650	0	4	_aDiterpenes _xmetabolism
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFarnesol _xmetabolism
650	0	4	_aFibroblasts _xcytology
650	0	4	_aG1 Phase _xdrug effects
650	0	4	_aGTP-Binding Proteins _xdrug effects
650	0	4	_aGenes, ras
650	0	4	_aLovastatin _xpharmacology
650	0	4	_aMethionine _xanalogs & derivatives
650	0	4	_aMevalonic Acid _xpharmacology
650	0	4	_aMice
650	0	4	_aProtein Prenylation _xdrug effects
650	0	4	_aProtein Serine-Threonine Kinases _xgenetics
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aProto-Oncogene Proteins c-raf
650	0	4	_aResting Phase, Cell Cycle _xdrug effects
650	0	4	_aS Phase _xdrug effects
650	0	4	_aTransferases _xantagonists & inhibitors
650	0	4	_arap GTP-Binding Proteins
650	0	4	_aras Proteins _xdrug effects
700	1		_aQian, Y
700	1		_aMcGuire, T F
700	1		_aHamilton, A D
700	1		_aSebti, S M
773	0		_tOncogene _gvol. 13 _gno. 9 _gp. 1991-9
999			_c8926957 _d8926957